![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/00 | |
C07K 14/47 | |||
A61K 39/00 |
(11) | Number of the document | 1951281 |
(13) | Kind of document | T |
(96) | European patent application number | 06826190.8 |
Date of filing the European patent application | 2006-10-17 | |
(97) | Date of publication of the European application | 2008-08-06 |
(45) | Date of publication and mention of the grant of the patent | 2015-04-15 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2006/040719 |
Date | 2006-10-17 |
(87) | Number | WO 2007/047764 |
Date | 2007-04-26 |
(30) | Number | Date | Country code |
726608 P | 2005-10-17 | US | |
728304 P | 2005-10-20 | US |
(72) |
SCHEINBERG, David, A., US
PINILLA-IBARZ, Javier, US
MAY, Rena, US
|
(73) |
Sloan Kettering Institute For Cancer Research,
1275 York Avenue, New York, NY 10021,
US
|
(54) | WT1 HLA CLASS II-BINDING PEPTIDES AND COMPOSITIONS AND METHODS COMPRISING SAME |
WT1 HLA CLASS II-BINDING PEPTIDES AND COMPOSITIONS AND METHODS COMPRISING SAME |